Influence of liver fibrosis stage on nevirapine plasma concentration in HIV-infected patients with chronic hepatitis C virus

被引：0
作者：
Gordana Dragovic
Colette Smith
Djordje Jevtovic
Mike Youle
David Back
机构：
[1] University of Belgrade,Institute of Pharmacology, Clinical Pharmacology and Toxicology, School of Medicine
[2] Royal Free and University College Medical School,Department of Primary Care and Population Sciences
[3] University of Belgrade,Institute of Infective and Tropical Disease “Dr Kosta Todorovic”, School of Medicine
[4] Royal Free and University College Medical School,Royal Free Centre for HIV Medicine
[5] University College London,Department of Pharmacology and Therapeutics
[6] University of Liverpool,undefined
来源：
BMC Infectious Diseases | / 14卷 / Suppl 4期
关键词：
Liver Fibrosis; Nevirapine; Fibrosis Stage; Liver Fibrosis Stage; Nevirapine Plasma;
D O I：
10.1186/1471-2334-14-S4-O17
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Causative factors of liver fibrosis in HIV-infected patients. A single center study [J].
Theodoros Androutsakos ;
Maria Schina ;
Abraham Pouliakis ;
Athanasios Kontos ;
Nikolaos Sipsas ;
Gregorios Hatzis .
BMC Gastroenterology, 20
[42]   Causative factors of liver fibrosis in HIV-infected patients. A single center study [J].
Androutsakos, Theodoros ;
Schina, Maria ;
Pouliakis, Abraham ;
Kontos, Athanasios ;
Sipsas, Nikolaos ;
Hatzis, Gregorios .
BMC GASTROENTEROLOGY, 2020, 20 (01)
[43]   Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients [J].
Merchante, N. ;
Macias, J. ;
Ramayo, E. ;
Vergara, S. ;
Garcia-Garcia, J. A. ;
Mira, J. A. ;
Corzo, J. E. ;
Gomez-Mateos, J. M. ;
Lozano, F. ;
Pineda, J. A. .
JOURNAL OF VIRAL HEPATITIS, 2006, 13 (07) :449-456
[44]   Opioid use and risk of liver fibrosis in HIV/hepatitis C virus-coinfected patients in Canada [J].
Brunet, L. ;
Moodie, E. E. M. ;
Cox, J. ;
Gill, J. ;
Cooper, C. ;
Walmsley, S. ;
Rachlis, A. ;
Hull, M. ;
Klein, M. B. .
HIV MEDICINE, 2016, 17 (01) :36-45
[45]   Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients [J].
Al-Mohri, H ;
Cooper, C ;
Murphy, T ;
Klein, MB .
HIV MEDICINE, 2005, 6 (06) :375-378
[46]   Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients [J].
Mariné-Barjoan, E ;
Saint-Paul, MC ;
Pradier, C ;
Chaillou, S ;
Anty, R ;
Michiels, JF ;
Sattonnet, C ;
Ouzan, D ;
Dellamonica, P ;
Tran, A .
AIDS, 2004, 18 (16) :2163-2170
[47]   Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study [J].
Dominguez, Stephanie ;
Ghosn, Jade ;
Peytavin, Gilles ;
Guiguet, Marguerite ;
Tubiana, Roland ;
Valantin, Marc Antoine ;
Murphy, Robert ;
Bricaire, Francois ;
Benhamou, Yves ;
Katlama, Christine .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (11) :2445-2449
[48]   Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients [J].
Marcelo Soto ;
Laura Sampietro-Colom ;
Luis Lasalvia ;
Aurea Mira ;
Wladimiro Jiménez ;
Miquel Navasa .
World Journal of Gastroenterology, 2017, 23 (17) :3163-3173
[49]   Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients [J].
Soto, Marcelo ;
Sampietro-Colom, Laura ;
Lasalvia, Luis ;
Mira, Aurea ;
Jimenez, Wladimiro ;
Navasa, Miquel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (17) :3163-3173
[50]   Liver fibrosis in Human inmunodeficiency Virus (HIV) and Hepatitis C virus (HCV) coinfected patients: Relationship with inmunological status [J].
Losada, E ;
Prieto, A ;
Villamil, I ;
Alende, R ;
Van den Eynde, A ;
Carballo, E ;
Perez-Becerra, E ;
Gude, F ;
Aguilera, A .
XIV INTERNATIONAL AIDS CONFERENCE: EPIDEMIOLOGY, 2002, :229-232
12345